BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Emisphere Technologies, Inc. (OB: EMIS)
0.2420 USD  +0.0070 (+2.98%)
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 16, 2014  /  Add to My Watchlist      
(EMIS) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 16, 2014
(Stock Blog Hub, 5/16/13)
Novo Nordisk A/S (NVO) and Emisphere Technologies, Inc. (EMIS) recently announced that they have modified their agreement for the development and commercialization of oral...(read more)
(market folly, 7/7/10)
MHR Fund Management run by Mark Rachesky recently filed a Form 4 with the SEC in regards to Emisphere Technologies (EMIS). Per the filing, Rachesky's firm received convertible notes on EMIS for...(read more)
(Bullish Bankers, 6/13/09)
Emisphere [[EMIS]] is an emerging bio-pharma company specializing in the development of a drug delivery technology platform for the oral administration of therapeutic compounds which are either...(read more)
Emisphere Technologies (EMIS) Company Overview

There is no analysis for EMIS yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here